• 제목/요약/키워드: adverse effect

검색결과 2,314건 처리시간 0.025초

Aerostatic load on the deck of cable-stayed bridge in erection stage under skew wind

  • Li, Shaopeng;Li, Mingshui;Zeng, Jiadong;Liao, Haili
    • Wind and Structures
    • /
    • 제22권1호
    • /
    • pp.43-63
    • /
    • 2016
  • In conventional buffeting theory, it is assumed that the aerostatic coefficients along a bridge deck follow the strip assumption. The validity of this assumption is suspect for a cable-stayed bridge in the construction stages, due to the effect of significant aerodynamic interference from the pylon. This situation may be aggravated in skew winds. Therefore, the most adverse buffeting usually occurs when the wind is not normal to bridge axis, which indicates the invalidity of the traditional "cosine rule". In order to refine the studies of static wind load on the deck of cable-stayed bridge under skew wind during its most adverse construction stage, a full bridge 'aero-stiff' model technique was used to identify the aerostatic loads on each deck segment, in smooth oncoming flow, with various yaw angles. The results show that the shelter effect of the pylon may not be ignored, and can amplify the aerostatic loading on the bridge deck under skew winds ($10^{\circ}-30^{\circ}$) with certain wind attack angles, and consequently results in the "cosine rule" becoming invalid for the buffeting estimation of cable-stayed bridge during erection for these wind directions.

Single and Two-Week Repeated] Oral Dose Toxicity Study of DHP2, a Hydrophobic Drug Delivery Vehicle in Mice

  • Han, Jung-Hee;Chung, He-Sson;Lee, Jong-Hwa;Suh, Jeong-Eun;Lee, Gab-Soo;Kim, Jong-Choon;Kang, Boo-Hyon
    • Toxicological Research
    • /
    • 제20권2호
    • /
    • pp.123-129
    • /
    • 2004
  • The present study was conducted to investigate the single and 2-week repeated dose toxicity of DHP2, a hydrophobic drug delivery vehicle, in ICR mice. The test article was administered orally to mice at the dose levels of 2.5, 12.5 and 37.5 g/kg for single dose toxicity study and at the dose levels of 0, 2.5, 5, and 10 g/kg for repeated dose toxicity study. In both studies, there were no treatment-related effects on mortality, clinical signs, food and water consumption, ophthalmoscopy, urinalysis, hematology, serum biochemistry, necropsy findings and organ weights of all animals treated DHP2. Based on these results, it was concluded that the 2-week repeated oral dose of DHP2 may have no toxic effect in mice at a dose level of 10 g/kg. In the condition of this study, the no-observed-adverse-effect level (NOAEL) was considered to be 10 g/kg/day for both sexes.

천연형 인성장호르몬 DA-3002의 단회 및 13주 반복투여독성연구 (Single and 13-week Repeated Dose Toxicity Study of DA-3002, An Authentic Recombinant Human Growth Hormone)

  • 김옥진;강경구;안병옥;백남기;이순복;김원배;양중익
    • Biomolecules & Therapeutics
    • /
    • 제2권2호
    • /
    • pp.161-172
    • /
    • 1994
  • This study was conducted to examine DA-3002, a biosynthetic human growth hormone, for its acute and subacute toxicities in mice and rats. The drug was administered subcutaneously and orally at a dose level of 1.0, 3.0, 8.9, 26.7 or 80.0 lU/kg once for single dose toxicity and given subcutaneously at a dose level of 0.34, 1.7 or 8.4 lU/kg daily for 13 weeks to investigate repeated dose toxicity. In the acute toxicity study, doses up to 80 lU/kg had no adverse effect on the behavior or body weight gain. Pathological examinations revealed no abnormal changes which could be attributed to toxic effect of DA-3002. In the subacute toxicity study, the growth hormone was tolerated well in broth mice and rats. No drug related deaths occurred and all animals appeared to be normal throughout the dosing period. Increases in body weight gain, food utilisation and absolute organ weights were observed in the rats in the high dose group. Mild changes in the blood chemical parameters were also seen in the treated groups. Histopathologically, however, no abnormal changes were observed in any organ. The changes noted during the treatment periods presumably represent exaggerated pharmacological effects of the growth hormone, and no observed adverse effect level (NOAEL) was considered to be more than 8.4 lu/kg/day.

  • PDF

삼정환의 랫드를 이용한 90일 반복 경구투여 독성시험 (Repeated Dose 90-Day Oral Toxicity Study of Modified Samjung-Hwan in Sprague-Dawley Rats)

  • 김민지;이명종;김호준
    • 한방비만학회지
    • /
    • 제18권1호
    • /
    • pp.36-49
    • /
    • 2018
  • Objectives: The study is aimed at evaluating the possible toxicity in 90-day repeated oral administration of modified Samjung-hwan (mSJH) in Sprague-Dawley (SD) rats. This study was conducted to detect the no-observed adverse effect level (NOAEL). Methods: Modified SJH extract was administered orally in male and female SD rats at dose of 0, 1,000, 2,000, 4,000 mg/kg. Each group consisted of 10 rats of each gender. The modified SJH extract was given once a day for 90 days. We monitored the changes of mortalities, clinical signs, body weight changes, food consumption, ophthalmologic findings, urine analysis, hematology, serum biochemistry, necropsy findings, organ weights, histological markers of all animals treated with modified SJH extract during the study period. Results: There were no toxicologically significant changes in mortalities, clinical signs, body weight gains, food consumption, ophthalmologic findings, urine analysis, hematology, serum biochemistry, necropsy findings, organ weights, histological markers in any of rats tested. Conclusions: The NOAEL of the modified SJH extract in male rats and no observed effect level (NOEL) in female rats are considered 4,000 mg/kg.

CT 조영제의 부작용 예방을 위한 표준진료지침서의 개발과 적용 (Development and Implementation of a Critical Pathway for Prevention of Adverse Reactions to Contrast Media for Computed Tomography)

  • 장근조;김명구;유병규;권대철
    • 대한방사선기술학회지:방사선기술과학
    • /
    • 제30권1호
    • /
    • pp.39-46
    • /
    • 2007
  • CT 조영제의 부작용을 예방하여 환자만족도와 방사선사 및 간호사의 업무만족도를 향상을 위해 표준진료지침서를 개발하고 적용하였다. 표준진료지침서 개발은 팀으로 구성하여 단계적으로 실시하였다. 대상은 환자 및 방사선사와 간호사를 대상으로 만족도를 평가하였다. 표준진료지침서를 적용하는 군이 만족도가 높게 조사되었고, 방사선사와 간호사는 표준진료지침서를 적용하는 경우 환자의 조영제 부작용 정보를 사전에 파악하는 효과와 조영제 부작용을 예방 효과가 있어 만족도가 증가하였다. 조영제 부작용은 표준진료지침서를 적용하기 전 90명에서 적용 후 66명으로 감소하는 효과가 있었다. 표준진료지침서를 적용하여 환자 정보제공(24%), 조영제 예방효과(19%), 조영제 부작용의 사전 인지효과(39%), 지식정도(19%)로 업무 만족도 향상 효과가 있었다. 혈관외유출은 표준진료지침서 적용전은 13건이었고, 적용 후는 6건으로 감소하였다. 혈관외유출 위치와 조영제 용량을 종합의료정보시스템(HMIS)에 입력하여 혈관외유출 예방과 검사 만족도를 높이는 효과가 있다. 환자 정보를 파악하여 조영제 부작용 예방효과와 처치로 의료 질 향상 및 만족도 증가하였다. 표준진료지침서를 지속적으로 적용하여 환자, 검사자의 만족도 및 의료질을 증진하도록 한다.

  • PDF

Nefazodons투여 후 지각이상을 보인 환자 4례 (Nefazodone and Associated Perceptual Disturbance : A Report of Four Cases)

  • 김지연;송형석;조방현;김용구
    • 생물정신의학
    • /
    • 제6권2호
    • /
    • pp.259-263
    • /
    • 1999
  • Nefazodone, a newer antidepressant is a phenylpiperazine derivative that inhibits the reuptake of both norepinephrine and serotonin, and antagonizes $5-HT_{2A}$ and ${\alpha}_1$ adrenergic receptors. Compared with SSRIs, nefazodone caused the fewer activating symptoms, adverse gastrointestinal effects(nausea, diarrhea, anorexia) and adverse effects of sexual function, but is associated with the more dizziness, dry mouth, constipation, visual disturbances and confusion. We report on 4 cases of visual disturbances and hallucinations in patients taking nefazodone. It is not certain what mechanisms mediated these side effects, but three mechanisms are possible. 1) Nefazodone, as a 5-HT2 antagonist, might induce visual disturbances. 2) mCPP, metabolite of nefazodone might contribute to the hallucination through action on 5-HT receptor. 3) Dopaminergic enhancing activity of nefazodone might cause hallucination. These case report raises the possibility that dose-related perceptual disturbances may exist with nefazodone. The fact emphasizes the need to pay close attention to all possible drug interactions, particularly in patients treated with multiple psychoactive agents, older patients, and patients with decreased hepatic function.

  • PDF

보기약(補氣藥)의 부량반응(不良反應)에 관한 문헌적 고찰 (A philological study on adverse effect of restoratives for invigorating qi(補氣藥))

  • 구진숙;박지하;서부일
    • 대한본초학회지
    • /
    • 제25권3호
    • /
    • pp.123-130
    • /
    • 2010
  • Objectives & Method:We investigated adverse symptoms, toxicity, treatment and prevention against adverse effects of restoratives for invigorating qi(補氣藥) in order to use herbal medicines accurately. Result:Ginseng Radix(人參), Codonopsis Pilosulae Radix(黨參), Panacis Quinquefolii Radix(西洋參), Astragali Radix(黃芪), Atractylodis Rhizoma Alba(白朮), Dioscoreae Rhizoma(山藥), Dolichoris Semen(白扁豆), Glycyrrhizae Radix(甘草), Jujubae Fructus(大棗) and Mel(蜂蜜) may give rise to some side effects, allergic reaction or toxic symptoms in restoratives for invigorating qi(補氣藥). The representative methods of poisoning treatment in western medicines are stopping medication, washing out the stomach, promotion of vomiting, causing diarrhea, supplies of grape sugar and symptomatic treatment, etc. The representative methods of poisoning treatment in oriental medicine take advantage of various herbs. And Oriental medical doctor should meet symptoms as patients call for attention. In order to prevent against poisoning of restoratives for invigorating qi(補氣藥), the patients should keep usage, dosage and notes. Conclusion:We should pay attention to clinical using of Ginseng Radix(人參), Codonopsis Pilosulae Radix(黨參), Panacis Quinquefolii Radix(西洋參), Astragali Radix(黃芪), Atractylodis Rhizoma Alba(白朮), Dioscoreae Rhizoma (山藥), Dolichoris Semen(白扁豆), Glycyrrhizae Radix(甘草), Jujubae Fructus(大棗) and Mel(蜂蜜) in restoratives for invigorating qi(補氣藥).

마우스를 이용한 십전대보탕(十全大補湯) 발효물의 단회투여 독성 연구 (Single Oral Dose Toxicity Test of Fermented Sipjeondaebo-tang Extracts in Mice)

  • 이지혜;김태수;곽동훈;마진열
    • 대한한방내과학회지
    • /
    • 제32권3호
    • /
    • pp.334-344
    • /
    • 2011
  • Objectives : Sipjeondaebo-tang is a medicine traditionally prescribed as a restorative. The aim of this study was to investigate the single oral dose toxicity and safety of extract of fermented Sipjeondaebo-tang in ICR mice. Methods : In single oral dose toxicity study, non-fermented or fermented Sipjeondaebo-tang were administered by oral gavage to ICR mice (5 males, 5 females) at single doses of varying concentrations: 1250, 2500 and 5000 mg/kg. Changes of body weight, general behavior, adverse effects and mortality were determined throughout the experimental period. Hematological parameters, organ weights and necropsy findings were evaluated at the end of the experiment. Results : There were no mortality or signs of toxicity in single oral dose toxicity studies. There were also no significant differences in body weight, organ weight, or hematological parameters between the treatment and control groups. Conclusions : Fermented Sipjeondaebo-tang did not cause remarkable adverse effects in ICR mice. The oral lethal dose of fermented Sipjeondaebo-tang is more than 5000 mg/kg and no-observed-adverse-effect level (NOAEL) of the extract for both male and female mice is 5000 mg/kg.

Air Pollution Exposure and Cardiovascular Disease

  • Lee, Byeong-Jae;Kim, Bumseok;Lee, Kyuhong
    • Toxicological Research
    • /
    • 제30권2호
    • /
    • pp.71-75
    • /
    • 2014
  • Ambient air pollution (AAP) and particulate matters (PM) have been closely associated with adverse health effects such as respiratory disease and cardiovascular diseases. Previous studies have examined the adverse health effects associated with short- and long-term exposure to AAP and outdoor PM on respiratory disease. However, the effect of PM size ($PM_{2.5}$ and $PM_{10}$) on cardiovascular disease has not been well studied. Thus, it remains unclear how the size of the inhalable particles (coarse, fine, or ultrafine) affects mortality and morbidity. Airborne PM concentrations are commonly used for ambient air quality management worldwide, owing to the known effects on cardiorespiratory health. In this article, we assess the relationship between cardiovascular diseases and PM, with a particular focus on PM size. We discuss the association of $PM_{2.5}$ and $PM_{10}$, nitrogen dioxide ($NO_2$), and elemental carbon with mortality and morbidity due to cardiovascular diseases, stroke, and altered blood pressure, based on epidemiological studies. In addition, we provide evidence that the adverse health effects of AAP and PM are more pronounced among the elderly, children, and people with preexisting cardiovascular and respiratory conditions. Finally, we critically summarize the literature pertaining to cardiovascular diseases, including atherosclerosis and stroke, and introduce potential studies to better understand the health significance of AAP and PM on cardiovascular disease.

Evidence for adverse effect of perinatal glucocorticoid use on the developing brain

  • Chang, Young Pyo
    • Clinical and Experimental Pediatrics
    • /
    • 제57권3호
    • /
    • pp.101-109
    • /
    • 2014
  • The use of glucocorticoids (GCs) in the perinatal period is suspected of being associated with adverse effects on long-term neurodevelopmental outcomes for preterm infants. Repeated administration of antenatal GCs to mothers at risk of preterm birth may adversely affect fetal growth and head circumference. Fetal exposure to excess GCs during critical periods of brain development may profoundly modify the limbic system (primarily the hippocampus), resulting in long-term effects on cognition, behavior, memory, co-ordination of the autonomic nervous system, and regulation of the endocrine system later in adult life. Postnatal GC treatment for chronic lung disease in premature infants, particularly involving the use of dexamethasone, has been shown to induce neurodevelopmental impairment and increases the risk of cerebral palsy. In contrast to studies involving postnatal dexamethasone, long-term follow-up studies for hydrocortisone therapy have not revealed adverse effects on neurodevelopmental outcomes. In experimental studies on animals, GCs has been shown to impair neurogenesis, and induce neuronal apoptosis in the immature brains of newborn animals. A recent study has demonstrated that dexamethasone-induced hypomyelination may result from the apoptotic degeneration of oligodendrocyte progenitors in the immature brain. Thus, based on clinical and experimental studies, there is enough evidence to advice caution regarding the use of GCs in the perinatal period; and moreover, the potential long-term effects of GCs on brain development need to be determined.